Evotec SE (EVO) Accounts Payables (2009 - 2026)
Evotec SE's (EVO) quarterly Accounts Payables came in at $57.1 million in Q2 2026, down 13.0% year-over-year from $65.6 million in Q2 2025, and down 11.15% quarter-over-quarter from $64.3 million in Q1 2026.
Analysis
Evotec SE (EVO) Accounts Payables (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Accounts Payables across 9 years of filings, most recently posting $57.1 million for Q2 2026.
- In Q2 2026, Accounts Payables fell 13.0% year-over-year to $57.1 million; the TTM figure through Jun 2026 stood at $57.1 million (down 13.0% YoY), while the FY2025 annual figure was $73.2 million, down 21.2% from the prior year.
- Accounts Payables came in at $57.1 million for Q2 2026 at Evotec SE, down from $64.3 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $144.5 million in Q4 2023 to a low of -$86.3 million in Q2 2022.
- Average Accounts Payables over 5 years is $71.0 million, with a median of $76.1 million recorded in 2024.
- Year-over-year, Accounts Payables soared 233.77% in 2023 and sank 36.56% in 2024.
- Over 5 years, Accounts Payables stood at $99.2 million in 2022, then soared by 45.62% to $144.5 million in 2023, then slumped by 36.56% to $91.7 million in 2024, then declined by 17.77% to $75.4 million in 2025, then fell by 24.25% to $57.1 million in 2026.
- Per Business Quant data, the three most recent Accounts Payables figures were $57.1 million in Q2 2026, $64.3 million in Q1 2026, and $75.4 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 37.53 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 140.98 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 118.24 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 54.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | 57.10 Mn |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 9.58 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 6.90 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 3.05 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 621,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.10 Mn |
| Mar 31, 2026 | 64.27 Mn |
| Dec 31, 2025 | 75.39 Mn |
| Sep 30, 2025 | 57.85 Mn |
| Jun 30, 2025 | 65.64 Mn |
| Mar 31, 2025 | 64.48 Mn |
| Dec 31, 2024 | 91.68 Mn |
| Sep 30, 2024 | 76.76 Mn |
| Dec 31, 2023 | 144.52 Mn |
| Jun 30, 2023 | 115.47 Mn |
| Dec 31, 2022 | 99.25 Mn |
| Sep 30, 2022 | 84.66 Mn |
| Jun 30, 2022 | -86.32 Mn |
| Mar 31, 2022 | 83.88 Mn |
| Dec 31, 2021 | 83.05 Mn |
| Sep 30, 2021 | 66.89 Mn |
| Dec 31, 2020 | 50.73 Mn |
| Sep 30, 2010 | 6.81 Mn |
| Jun 30, 2010 | 7.19 Mn |
| Mar 31, 2010 | 7,736.37 |